Interport Ltd was established by the Managing Director, H. Patel, in 1982 to import, label and distribute pharmaceutical products. Already the owner of a well-known chain of successful chemist shops - EM-ESS (Chemists) Ltd., in Liverpool, he sold these in 1994 to concentrate wholly on the opportunities in the wholesale business.
In 2001, 2002, 2003, 2004 Deloitte and Touche in The Independent on Sunday, congratulated Interport on being one of the UK�s fastest growing companies.
We were voted number 30 on the 2000 Virgin Atlantic Fast Track 100 league table, and number 32 in 1999.
Interport has concentrated upon the opportunities presented by the growing market for Parallel Imported products within the UK.
P.I. or Parallel Importing (Imported Ethicals) is the sourcing of branded products in European (E.U.) markets and importing them into the UK, where they are distributed in competition with identical products supplied by the original manufacturer.
A generic drug is marketed under the chemical name of the principle active ingredient rather than a brand name. Generic drugs can only be sold after any patent protection covering the original branded drug has expired. Generic drugs are marketed alongside the original branded drug and are often considerably cheaper.
|FY, 2013||FY, 2014||FY, 2015|
|£121.1 m||£113.1 m||£57 m|
Revenue growth, %
Cost of sales
|£112.3 m||£111.6 m||£55.1 m|
|£8.9 m||£1.5 m||£1.9 m|
Gross profit Margin, %
Operating expense total
|£4.2 m||£3 m||£3.2 m|